Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medical Device Innovation Consortium Sets Priorities To Advance Regulatory Science

Executive Summary

The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.” This month: Heads of the newly formed private-public partnership comprising industry, academia, and FDA describe the group’s top three projects to advance medical device regulatory science.

You may also be interested in...



Medical Device Innovation Consortium Launches, Aims To Start Projects In 2013

The first public-private partnership to focus on promoting medical device regulatory science, known as the Medical Device Innovation Consortium, aims to speed up patient access to medical device technologies.

CDRH Entrepreneurs Take Two: Streamlining Data Collection And The Path To Reimbursement

FDA’s device center launched the second round of its entrepreneurs-in-residence program, bringing in outside experts to the center to focus on streamlining data collection and the approval-to-reimbursement pathway.

CDRH Launches Patients’ Preference Project

Associate director for science at FDA’s device center highlights ongoing efforts to incorporate more quantitative patient input in device reviews.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035630

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel